Overall, small Akt and JNK kinase inhibitors significantly enhance the anti-GBM effects of the menadione and ascorbic acid combination, achieved through the potentiation of autophagy and the amplification of deleterious ROS levels [271]. Here, AKT1 is linked to glioblastoma.